Hormonal contraceptive eligibility for women at high risk of HIV

Guidance statement
by Caroline Phiri Chibawe, Alison Edelman, Chelsea Polis et al.
World Health Organization, 2017

20 pp. 2.5 MB
http://apps.who.int/iris/bitstream/10665/254662/1/WHO-RHR-17.04-eng.pdf?ua=1

In response to continued questions as to whether the use of hormonal contraception increases the risk of HIV acquisition, the World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime risk of acquiring HIV, hormonal contraceptives constitute a significant component of the contraceptive method mix and unintended pregnancy is a common threat to the well-being and lives of women and girls.

(Visited 22 times, 1 visits today)
This entry was posted in Essential Medicines, General, HIV - AIDS - STI, Maternal & Child Health, Sexual & Reproductive Health. Bookmark the permalink.